FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pilar Lianes

Research Profile

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jordi Remon; Pilar Lianes; Susana Martínez
Brain metastases from renal cell carcinoma. Should we change the current standard?
Pilar Lianes; Jordi Remon; Isabel Bover; Dolores Isla
SEOM guidelines for the treatment of malignant pleural mesothelioma.
Fernanda Salazar; Miguel Angel Molina; Maria Sanchez-Ronco; Teresa Moran; Jose Luis Ramirez; Jose Miguel Sanchez; Rolf Stahel; Pilar Garrido; Manuel Cobo; Dolores Isla; Jordi Bertran-Alamillo; Bartomeu Massuti; Felipe Cardenal; Christian Manegold; Pilar Lianes; José M Trigo; Jose Javier Sanchez; Miquel Taron; Rafael Rosell
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pilar Lianes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jordi Remon; Pilar Lianes; Susana Martínez
Brain metastases from renal cell carcinoma. Should we change the current standard?
Cancer treatment reviews 2012;38(4):249-57.
2011: Pilar Lianes; Jordi Remon; Isabel Bover; Dolores Isla
SEOM guidelines for the treatment of malignant pleural mesothelioma.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2011;13(8):569-73.
2011: Fernanda Salazar; Miguel Angel Molina; Maria Sanchez-Ronco; Teresa Moran; Jose Luis Ramirez; Jose Miguel Sanchez; Rolf Stahel; Pilar Garrido; Manuel Cobo; Dolores Isla; Jordi Bertran-Alamillo; Bartomeu Massuti; Felipe Cardenal; Christian Manegold; Pilar Lianes; José M Trigo; Jose Javier Sanchez; Miquel Taron; Rafael Rosell
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2011;72(1):84-91.
2008: Rafael Rosell; Rolf Stahel; Jose Manuel Trigo; Jia Wei; Remei Blanco; Pilar Garrido; Pilar Lianes; Christian Manegold; Teresa Moran; Miquel Taron
Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer.
Clinical lung cancer 2008;9 Suppl 2():S76-82.
2006: Fabio Efficace; andrew bottomley; Egbert F Smit; Pilar Lianes; Catherine Legrand; Channa Debruyne; Franz Schramel; Hans J M Smit; Rabab Mohamed Gaafar; Bonne Biesma; Christian Manegold; Corneel Coens; Giuseppe Giaccone; Jan P van Meerbeeck
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1698-704.
2005: Niels Neymark; Pilar Lianes; Egbert F Smit; Jan P van Meerbeeck
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer.
PharmacoEconomics 2005;23(11):1155-66.
2004: Josep Tabernero; Luis Paz-Ares; Ramon Salazar; Pilar Lianes; José Guerra; Joan Borrás; Humberto Villavicencio; Oscar Leiva; Hernán Cortés-Funes
Incidence of contralateral germ cell testicular tumors in South Europe: report of the experience at 2 Spanish university hospitals and review of the literature.
The Journal of urology 2004;171(1):164-7.
2003: Egbert F Smit; Jan P van Meerbeeck; Pilar Lianes; Channa Debruyne; Catherine Legrand; Franz Schramel; Hans Smit; Rabab Mohamed Gaafar; Bonne Biesma; Chris Manegold; Niels Neymark; Giuseppe Giaccone
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3909-17.
2003: Andrea Ardizzoni; Christian Manegold; Channa Debruyne; Rabab Mohamed Gaafar; Erika Buchholz; Egbert F Smit; Pilar Lianes; Guul P M ten Velde; Lionel Bosquee; Catherine Legrand; Carlo Emanuele Neumaier; Kathrine King
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):143-50.
2002: F de la Rosa; Rocio Garcia-Carbonero; J Passas; A Rosino; Pilar Lianes; Luis Paz-Ares
Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
The Journal of urology 2002;167(6):2413-8.
2000: José M Trigo; Josep Tabernero; Luis Paz-Ares; J L García-Llano; J Mora; Pilar Lianes; E Esteban; R Salazar; J J López-López; Hernán Cortés-Funes
Tumor markers at the time of recurrence in patients with germ cell tumors.
Cancer 2000;88(1):162-8.
1998: Giuseppe Giaccone; Ted A W Splinter; Channa Debruyne; G S Kho; Pilar Lianes; nico van zandwijk; M C Pennucci; Giorgio V Scagliotti; Jan P van Meerbeeck; Q van Hoesel; Desmond Curran; TM Sahmoud; Pieter E Postmus
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2133-41.
1998: Daniel Castellano; Pilar Lianes; Luis Paz-Ares; Manuel Hidalgo; J A Guerra; C Gómez-Martín; H Gómez; J Calzas; Hernán Cortés-Funes
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):457-9.
1998: J Calzas; Pilar Lianes; Hernán Cortés-Funes
[Heart pathology of extracardiac origin. VII. Heart and neoplasms].
Revista española de cardiología 1998;51(4):314-31.
1997: Consuelo Fernández-Miranda; N Schoebel; A Angulo; Luis Paz-Ares; Pilar Lianes; Amalia del Palacio
[Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy].
Revista clínica española 1997;197(7):490-3.
1997: Manuel Hidalgo; Luis Paz-Ares; F Rivera; Pilar Lianes; G Huidobro; A Ruiz; M López-Brea; J Sanz-Ortiz; J López López; Hernán Cortés-Funes; Josep Tabernero
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):555-9.
1995: José I Mayordomo; F Rivera; M T Díaz-Puente; Pilar Lianes; ramon colomer; M López-Brea; E López; Luis Paz-Ares; Ricardo Hitt; I García-Ribas
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
Journal of the National Cancer Institute 1995;87(11):803-8.
1994: José I Mayordomo; Luis Paz-Ares; M T Diaz-Puente; Pilar Lianes; M D Garcia-Prats; Hernán Cortes-Funes
Prognostic factors for women with ovarian germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1737-8.
1994: Luis Paz-Ares; Pilar Lianes; Hernán Cortes-Funes
The management of non-seminomatous germ cell tumours (GCT).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):457-62.
1994: José I Mayordomo; Luis Paz-Ares; F Rivera; M López-Brea; E López Martín; C Mendiola; M T Díaz-Puente; Pilar Lianes; M D García-Prats; Hernán Cortés-Funes
Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):225-31.
1993: José I Mayordomo; F Rivera; M T Diaz-Puente; Pilar Lianes; Hernán Cortes-Funes
Re: Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy.
Journal of the National Cancer Institute 1993;85(15):1251-3.
1993: Luis Paz-Ares; Pilar Lianes; M Díaz-Puente; F Rivera; J Passas; P Costas; C Mendiola; Hernán Cortés-Funes
CMV front-line chemotherapy in transitional bladder carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(2):147-50.